SEC Form 4 · accession 0001562180-18-003761
Sage Therapeutics, Inc. · SAGE
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James M Frates
Director
Period of report
Aug 22, 2018
Accepted (ET)
Aug 23, 2018 · 5:20 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001597553
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Aug 22, 2018 | G | 700 | — | D | 4,300 | D | |
| Common StockF2 | Aug 22, 2018 | G | 65 | — | D | 4,235 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On August 22, 2018, the reporting person made a charitable gift of 700 shares. No compensation was given to the reporting person for the gifted shares.
- F2On August 22, 2018, the reporting person made a charitable gift of 65 shares. No compensation was given to the reporting person for the gifted shares.